 SAN DIEGO, March 08, 2022 GLOBE NEWSWIRE -- Exagen Inc. Nasdaq: XGN, a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December 31, 2021 after the market close on Tuesday, March 22, 2022. Ron Rocca, Exagens President and Chief Executive Officer, Kamal Adawi, Chief Financial Officer, and Mark Hazeltine, Chief Operating Officer, will host a conference call to review the Companys results at 4:30 PM ET 1:30 PM PT. 